AU762353B2 - An improved process for the preparation of thiazolidine-2,4-dione derivatives - Google Patents

An improved process for the preparation of thiazolidine-2,4-dione derivatives Download PDF

Info

Publication number
AU762353B2
AU762353B2 AU54399/99A AU5439999A AU762353B2 AU 762353 B2 AU762353 B2 AU 762353B2 AU 54399/99 A AU54399/99 A AU 54399/99A AU 5439999 A AU5439999 A AU 5439999A AU 762353 B2 AU762353 B2 AU 762353B2
Authority
AU
Australia
Prior art keywords
formula
reaction
compound
hours
dione
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU54399/99A
Other languages
English (en)
Other versions
AU5439999A (en
Inventor
Prabhakar Chebiyyam
Om Reddy Gaddam
Chinna Bakki Reddy Gade
Ramabhadra Sarma Mamillapalli
Rajender Kumar Potlapally
Balaram Mahanti Satish
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Reddys Laboratories Ltd
Original Assignee
Dr Reddys Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Reddys Laboratories Ltd filed Critical Dr Reddys Laboratories Ltd
Publication of AU5439999A publication Critical patent/AU5439999A/en
Assigned to DR. REDDY'S LABORATORIES LIMITED reassignment DR. REDDY'S LABORATORIES LIMITED Alteration of Name(s) of Applicant(s) under S113 Assignors: DR. REDDY'S RESEARCH FOUNDATION
Application granted granted Critical
Publication of AU762353B2 publication Critical patent/AU762353B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU54399/99A 1998-09-14 1999-09-10 An improved process for the preparation of thiazolidine-2,4-dione derivatives Ceased AU762353B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN2060/MAS/98 1998-09-14
IN2060MA1998 IN187716B (enExample) 1998-09-14 1998-09-14
PCT/IB1999/001530 WO2000015638A1 (en) 1998-09-14 1999-09-10 An improved process for the preparation of thiazolidine-2,4-dione derivatives

Publications (2)

Publication Number Publication Date
AU5439999A AU5439999A (en) 2000-04-03
AU762353B2 true AU762353B2 (en) 2003-06-26

Family

ID=11096874

Family Applications (1)

Application Number Title Priority Date Filing Date
AU54399/99A Ceased AU762353B2 (en) 1998-09-14 1999-09-10 An improved process for the preparation of thiazolidine-2,4-dione derivatives

Country Status (24)

Country Link
US (1) US6469167B1 (enExample)
EP (1) EP1114047B1 (enExample)
JP (2) JP2002524563A (enExample)
KR (1) KR100448179B1 (enExample)
CN (2) CN1231481C (enExample)
AT (1) ATE234834T1 (enExample)
AU (1) AU762353B2 (enExample)
BR (1) BR9914493A (enExample)
CA (1) CA2343883C (enExample)
CZ (1) CZ300933B6 (enExample)
DE (1) DE69906100T2 (enExample)
DK (1) DK1114047T3 (enExample)
ES (1) ES2195600T3 (enExample)
HU (1) HU229519B1 (enExample)
IL (1) IL141737A0 (enExample)
IN (2) IN187716B (enExample)
NO (1) NO317383B1 (enExample)
NZ (1) NZ510316A (enExample)
PL (1) PL195617B1 (enExample)
PT (1) PT1114047E (enExample)
RU (1) RU2223961C2 (enExample)
UA (1) UA70962C2 (enExample)
WO (1) WO2000015638A1 (enExample)
ZA (1) ZA200101699B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4634716B2 (ja) * 2002-03-15 2011-02-16 ドクター・レディーズ・ラボラトリーズ・リミテッド ５−［４−［［３−メチル−４−オキソ−３，４−ジヒドロキナゾリン−２−イル］メトキシ］ベンジル］チアゾリジン−２，４−ジオンカリウム塩の新規な結晶形
CN103288757B (zh) * 2013-05-16 2015-07-01 苏州明锐医药科技有限公司 6-氨基-7-羟基-3,4-二氢喹唑啉-4-酮的制备方法
KR101677340B1 (ko) 2014-11-28 2016-11-29 이청주 광고용 열기구
KR20160134615A (ko) 2016-11-11 2016-11-23 이청주 광고용 열기구
CN109867765A (zh) * 2019-02-28 2019-06-11 中山大学惠州研究院 一种长效缓释可降解防污聚氨酯及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB306228A (en) * 1927-12-15 1929-02-21 Bohn Aluminium & Brass Corp Improvements in pistons
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
EP0839812A1 (en) * 1990-04-27 1998-05-06 Sankyo Company Limited Preparation of benzylthiazolidine derivatives
EP0590793B1 (en) * 1992-08-31 1999-10-13 Sankyo Company Limited Oxazolidine derivatives having anti-diabetic and anti-obesity properties, their preparation and their therapeutic uses
FR2696743B1 (fr) * 1992-10-12 1994-12-23 Adir Nouveaux composés de thiazolidine dione, leur procédé de préparation et les compositions pharmaceutiques les contenant.
TW399051B (en) * 1996-01-31 2000-07-21 Ssp Co Ltd A novel benzoazine thiazolidinedione derivative and pharmaceutical composition for reducing blood glucose
BR9711098B1 (pt) * 1996-07-01 2011-10-04 compostos heterocìclicos, processo para sua preparação e composições farmacêuticas contendo os mesmos e seu uso no tratamento de diabetes e doenças relacionadas.
US5885997A (en) * 1996-07-01 1999-03-23 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
DE69723869T2 (de) * 1996-12-31 2004-04-22 Dr. Reddy's Laboratories Ltd. Heterozyklische verbindungen, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen die diese enthalten und ihre anwendung in der behandlung von diabetis und verwandten krankheiten

Also Published As

Publication number Publication date
JP2002524563A (ja) 2002-08-06
DK1114047T3 (da) 2003-06-23
NO20011265L (no) 2001-05-14
IL141737A0 (en) 2002-03-10
HU229519B1 (en) 2014-01-28
RU2223961C2 (ru) 2004-02-20
CN1231481C (zh) 2005-12-14
IN189187B (enExample) 2003-01-04
KR100448179B1 (ko) 2004-09-10
HUP0103517A2 (hu) 2002-05-29
CZ2001825A3 (cs) 2001-08-15
CN1323305A (zh) 2001-11-21
ZA200101699B (en) 2002-05-28
HK1077814A1 (en) 2006-02-24
NO20011265D0 (no) 2001-03-13
NO317383B1 (no) 2004-10-18
ATE234834T1 (de) 2003-04-15
PL346532A1 (en) 2002-02-11
UA70962C2 (uk) 2004-11-15
BR9914493A (pt) 2001-06-26
PT1114047E (pt) 2003-07-31
PL195617B1 (pl) 2007-10-31
CN1616439A (zh) 2005-05-18
JP2011144179A (ja) 2011-07-28
KR20010075088A (ko) 2001-08-09
CA2343883A1 (en) 2000-03-23
CZ300933B6 (cs) 2009-09-16
US6469167B1 (en) 2002-10-22
HUP0103517A3 (en) 2003-06-30
EP1114047A1 (en) 2001-07-11
IN187716B (enExample) 2002-06-15
CN1295222C (zh) 2007-01-17
NZ510316A (en) 2002-11-26
EP1114047B1 (en) 2003-03-19
CA2343883C (en) 2010-02-16
AU5439999A (en) 2000-04-03
DE69906100D1 (de) 2003-04-24
DE69906100T2 (de) 2003-12-11
WO2000015638A1 (en) 2000-03-23
ES2195600T3 (es) 2003-12-01

Similar Documents

Publication Publication Date Title
Jouin et al. Stereospecific synthesis of N-protected statine and its analogues via chiral tetramic acid
EP1114047B1 (en) An improved process for the preparation of thiazolidine-2,4-dione derivatives
WO2000010986A1 (en) Process for the preparation of (2r, 3s)-3-amino-1,2-oxirane
JPH06145148A (ja) 新規ベンズアゼピノン誘導体
Veeraswamy et al. Synthesis of novel 5-substituted isoxazole-3-carboxamide derivatives and cytotoxicity studies on lung cancer cell line
EP1197490A1 (en) Process for preparing N-[1-(S)-ethoxycarbonyl-3-phenylpropyl]-L-alanine N-carboxyanhydride
HU201921B (en) New process for producing 6-acylforscholine derivatives
CA2461296C (en) Enzymatic process for the preparation of substituted 2-amino-3-(2-amino-phenylsulfanyl)-propionic acid
MXPA01002550A (en) An improved process for the preparation of thiazolidine-2,4-dione derivatives
KR100856133B1 (ko) 아토르바스타틴의 개선된 제조방법
JPS6216445A (ja) 不斉ヒダントインの製造における中間体
JP4075357B2 (ja) ４，５−ジ置換−１，２，３−トリアゾール及びその製造法
JPH0557988B2 (enExample)
KR100374405B1 (ko) 암로디핀 베실레이트의 제조방법
JP2001502686A (ja) Ｎ▲下α▼―２―（４―ニトロフェニルスルホニル）エトキシカルボニル―アミノ酸
JP2520777B2 (ja) アリ―ルチオアルキルカルボン酸誘導体
JP2520776B2 (ja) ナフチルチオアルキルカルボン酸誘導体
JPH11209345A (ja) 医薬品の中間体の製造方法
EP0990637A1 (en) Process for producing ketoprofen and 5-benzoyl-3-methyl-2-indolinone
RU2109738C1 (ru) Способ получения 3-алкоксикарбонил-4-гидрокси-2-метил-2н-1,2-бензотиазин-1,1-диоксидов
KR0139260B1 (ko) 고리화된 이미다졸을 가지는 벤즈이미다졸 유도체
JP2001302611A (ja) ５−トリフルオロメチルジヒドロウラシルの製造法
WO2000020412A1 (fr) Derives de quinazolinedione, leurs preparations et leurs applications en therapeutique
JPH07215968A (ja) アゼラスチンの製造方法
JPH0584300B2 (enExample)

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: DR. REDDY'S LABORATORIES LIMITED

Free format text: THE FORMER OWNER WAS: DR. REDDY'S RESEARCH FOUNDATION

FGA Letters patent sealed or granted (standard patent)